Industry trade groups ask FDA to “significantly revise” its draft guidance on safety and effectiveness data needed for OTC sunscreen ingredients and produce a “modern version based on advances in toxicological risk assessment.”
“We believe the draft guidance proposes a framework that is not reflective of the current state-of-art in ingredient safety assessment,” say the Consumer Healthcare Products Association and the Personal Care Products Council in Feb. 22